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Laparoscopy is increasingly being recommended in order to reduce postoperative complica-
tions among sickle cell disease patients undergoing cholecystectomy. Acute chest syndrome
is the most deadly of these complications. The purpose of this study was to assess if laparo-
scopic approach reduces postoperative complications related to sickle cell disease after cho-
lecystectomy. A retrospective study of records of sickle cell patients who underwent
cholecystectomy for cholelithiasis, from January 1990 to December 2005 was conducted.
136 sickle cell patients underwent surgery: 47 (34.5%) by laparoscopy and 89 (63.5%) by lap-
arotomy. The mean operative time was 71.4 18.9 min in the laparoscopy group and
61.2 15.3 min in the laparotomy group (non-significant difference). The mortality was
not significantly different between the two groups: one patient died in the open cholecystec-
tomy group but no death occurred in the laparoscopic one. The morbidity related to the
sickle cell disease was significantly higher in the laparoscopy group [n¼ 5 (10.5%)] than in
the laparotomy group [n¼ 4 (4.5%)] ( p¼ 0.04). This difference was associated with a higher
rate of acute chest syndrome in the laparoscopy group [n¼ 4 (8, 5%)] compared to that in
the laparotomy group [n¼ 1 (1.1%)] ( p¼ 0.01). There were more complications related to
sickle cell disease in the laparoscopy group due to acute chest syndrome. Thus, these data
should be confirmed in further randomized studies which must be undertaken.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction patients free of sickle cell disease, laparoscopic approach isCholelithiasis is a frequent complication of sickle cell disease.
Prevalence rate ranges from30% to 70%.1 Three quarter of these
patients become symptomatic,2 needing cholecystectomy. Forstive Surgery, University
758437.
rra).
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al Associates Ltd. Publishconsidered as the gold standard of cholecystectomy. For sickle
cell patients, some studies have shown that laparoscopic cho-
lecystectomy was feasible.3–7 But patients with sickle cell dis-
ease who undergo cholecystectomy are generally consideredHospital of Fort-de-France, BP 632 – 97261 Fort-de-France Cedex,
ed by Elsevier Ltd. All rights reserved.
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tients without sickle cell disease.7,8 The most dangerous com-
plication is the acute chest syndrome because of its high
mortality rate.8
Although improvements have been made in perioperative
management of sickle cell disease patients who undergo
open cholecystectomy (oxygen therapy, hydratation, and
transfusion),7,9,10 the effect of laparoscopy in promoting acute
chest syndrome has not been well studied. In fact, the insuf-
flated CO2 is absorbed and can lead to a metabolic acidosis
which is a major cause of the red blood cells’ falciformation.11
Moreover, the increase of the intra-abdominal pressure dur-
ing the laparoscopy can equally cause hypoventilation by re-
ducing the diaphragm elevation. So, these two facts could
combine and increase the risk of evolving an acute chest syn-
drome after laparoscopic cholecystectomy.
The aim of our study was to compare the outcome of open
surgery versus laparoscopic approach in sickle cell disease pa-
tients with symptomatic cholelithiasis who underwent
cholecystectomy.Table 1 – Characteristics of severity of the sickle cell
disease
Haemoglobin type LC (n¼ 47) OC (n¼ 89)
SSFA2 55.3% (n¼ 26) 61.8% (n¼ 55)
SFA2 4.3% (n¼ 2) 5.6% (n¼ 5)
SAFA2 12.8% (n¼ 6) 10.1% (n¼ 9)
SC 27.6% (n¼ 13) 22.5% (n¼ 20)
LC, laparoscopy cholecystectomy; OC, open cholecystectomy.
Non-significant difference.2. Patients and methods
We reviewed the records of all sickle cell disease patients who
underwent cholecystectomy for cholelithiasis from October
1990 to September 2005. The data were analysed by Epi
Info6. A cholecystectomy was performed in sickle cell pa-
tients with symptomatic cholelithiasis whether for biliary
colic, gallbladder sludge, microlithiasis or acute cholelithiasis.
Sickle cell patients were patients who were homozygous
with haemoglobin S detected by electrophoresis. With regard
to the type of haemolysis, these patients were divided into
two groups: those who experienced chronic haemolysis (phe-
notype SSFA2 and SFA2) and others who experienced acute
haemolysis (phenotype SC and SAFA2). Patients with chronic
haemolysis and anaemia (SSFA2 and SFA2) are considered to
have more severe sickle cell disease symptoms than those
with few acute haemolysis (SSFA2 and SFA2). Patients with
haemoglobinAAorASandpatientswithconcomitant choledo-
cotomy or bilio-intestinal diversion during cholecystectomy
(n¼ 4) were excluded of the study. Records with incomplete
data were also excluded (n¼ 13). Sickle cell disease–related
morbiditywas defined as postoperative complications directly
linked to sickle cell disease.Other postoperative complications
were defined as general morbidity. The choice of the approach
of cholecystectomy (laparoscopy versus open cholecystec-
tomy) was made based on discussion between the surgeon
and the patient. Laparoscopy was performedwith four trocars
(a periumbilical trocar and three additional trocars in epigas-
tric, right and left hypochondriac region) after creating a 12-
mmHg blinded pneumoperitoneum with a Veress needle.
Each patient has had the same perioperative management, in
order to avoid vaso-occlusion crisis: hyperhydratation, oxygen
therapy, warming up, pain control and transfusion if needed.
Acute chest syndromewas defined as the onset of a new lo-
bar infiltration on chest X-ray, excluding atelectasis, accom-
panied by fever greater than 38.5 C, cough, dyspnoea and
commonly pleuritic pain.11,12 Statistical analysis has
compared two groups: sickle cell patients operated bylaparoscopic cholecystectomy and those operated by open
cholecystectomy.We first compared the epidemiological, clin-
ical and therapeutic data to assess whether the two groups
were comparable. Then, we compared the general and sickle
cell disease–related morbidity and the mortality rate to assess
the outcomes according to the cholecystectomy approach.
This analysis was performed using the Epi Info6 software, us-
ing the c2, Student and Fisher non-parametric test.3. Results
136 sickle cell patients with symptomatic cholelithiasis un-
derwent cholecystectomy: 47 (34.5%) by laparoscopy and 89
(65.5%) by open surgery. The distribution of biological charac-
teristics predictive of sickle cell disease severity (chronic hae-
molysis phenotypes and acute haemolysis phenotypes) was
homogenous between laparoscopy group and open cholecys-
tectomy group: 56.6% (n¼ 28) and 40.4% (n¼ 19) versus 67.4%
(n¼ 60) and 32.6% (n¼ 29) [non-significant difference] (Table 1).
The difference in clinical and paraclinical characteristic be-
tween the two groups was not significant (Table 2). So, the
two groups were similar. The mean operating time was
71 17 min in laparoscopy group and 62 12 min in open cho-
lecystectomy group. Themean hospital staywas, respectively,
7.7 1.7 days and 6.2 2.1 days. There was no death in lapa-
roscopy group but one patient died in the other one [non-sig-
nificant difference]. The death occurred after an acute
haemolysis crisis. Themorbidity rate non-related to the sickle
cell disease was not significantly different between the lapa-
roscopy group 27.6% (n¼ 14) and the other one 22.5% (n¼ 20)
[Table 3]. But there wasmore sickle cell–related complications
in the laparoscopy group compared to open cholecystectomy
group [14.9% versus 4.5% ( p¼ 0.04)] (Table 4).4. Discussion
For sickle cell disease–free patients, laparoscopic approach is
widely admitted to be the gold standard of cholecystectomy.
Among sickle cell patients, the feasibility has been demon-
strated by numerous studies for children and adult.1,3,6,7,12–15
They suggested that the outcomes of the two approaches
were similar.1,3,13–15 Moreover, some of these studies reported
that laparoscopic cholecystectomy for sickle cell disease
Table 2 – Comparison of perioperative data
CL (n¼ 47) OC (n¼ 89)
Median age (yr) 25.5 9.7 27.3 7.1
Sex (M:F) 61.7% (29/18) 43.8% (39/50)
Hepatic colic 12.8% (n¼ 6) 10.1% (n¼ 9)
Cholecystitis 87.2% (n¼ 41) 90% (n¼ 81)
Gangrenous of the gallbladder 36.2% (n¼ 17) 50.6% (n¼ 45)
Haemoglobin level (g/dl) 10.7 1.9 10.7 1.9
Preoperative transfusion 78.7% (n¼ 37) 67.4% (n¼ 60)
Accidental opening
of gallbladder
23.4% (n¼ 11) 17.9% (n¼ 17.9)
Intraoperative desaturation 2.1% (n¼ 1) 3.4% (n¼ 3)
LC, laparoscopy cholecystectomy; OC, open cholecystectomy.
Non-significant difference.
Table 4 – Postoperative complications related to sickle cell
disease
CL (n¼ 47) OC (n¼ 89) p
Morbidity related
to SCD
14.9% (n¼ 7) 4.5% (n¼ 4) 0.04
(Fischer test)
Acute haemolysis 4.3% (n¼ 2) 3.4% (n¼ 3)
Stroke 0% (n¼ 0) 0% (n¼ 0)
Acute chest syndrome 10.6% (n¼ 5) 1.1% (n¼ 1) 0.01
(Fischer test)
SCD, sickle cell disease.
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postoperative pain, early deambulation and hospital stay.1,3,6,7
However, our results showed that there were more sickle
cell–related complications in laparoscopic group compared to
open cholecystectomy, due to acute chest syndrome. The
same results have been reported by Wales 12 and Delatte et
al.16 Wales reported acute chest syndrome in 22.7% in laparo-
scopic group versus 15.4% in open cholecystectomy group. In
another report from Delatte et al., the incidence of acute chest
syndrome was higher in laparoscopic group (10.2% versus
0.4%). These data must be taken into account in the choice of
the safest approach for sickle cell patientswhohave to undergo
surgery, having regard to the mortality rate of acute chest syn-
drome. In fact, acute chest syndrome is known to be the leading
cause of death in sickle cell disease patients because of its high
rate ofmortality.8,17–19 The effect of pneumoperitoneum in pro-
motingacute chest syndrome ismoreandmoreunderstood. Po-
lymerisation of deoxygenated sickle haemoglobin is the primum
movensofall the illnessof sickle cell disease.Thepolymerisation
of deoxygenated sickle haemoglobin makes red blood cells less
pliable anddeforms someof them. These cells cannot easilyne-
gotiate capillary beds, resulting in premature haemolysis and
vaso-occlusion.11 Haemolysis and vaso-occlusion are the rea-
sons of all the symptoms and perioperative complication such
as acute chest syndrome. During the procedure of laparoscopy,
the sole site of excretion of the insufflated carbon dioxide (CO2)
is the lung. Despite vigorous intraoperative hyperventilation,Table 3 – Postoperative complications non-related to
sickle cell disease
CL (n¼ 47) OC (n¼ 89) p
Mortality 0% (n¼ 0) 1.1% (n¼ 1) 0.65 (Fischer)
Morbidity
non-related to SCD
27.6%
(n¼ 14)
22.5%
(n¼ 20)
0.34 (c2)
Fever 12.8% (n¼ 6) 4.5% (n¼ 12)
Wound infection 0% (n¼ 0) 0% (n¼ 0)
Abdominal infection 0% (n¼ 0) 0% (n¼ 0)
Biliary fistula 0% (n¼ 0) 0% (n¼ 0)
Pulmonary infection 4.2% (n¼ 2) 2.2% (n¼ 2)
Urinary tract infection 2.1% (n¼ 1) 2.2% (n¼ 2)
Deep vein thrombosis 0% (n¼ 0) 0% (n¼ 0)
SCD, sickle cell disease.patients remain hyperbaric and acidotic, which cause sickle
erythrocytes, thereby precipitating vaso-occlusion and acute
chest syndrome.20 In contrast to other vascular beds, the lung
vasculature constrictwithhypoxia, by the roleof free radicals.21
In an underventilated lung, sickle cells remain deoxygenated,
that led to perioperative hypoxia, hypoperfusion and acidosis:
areas of ischemia/reperfusion develop, increasing production
of oxidizingmolecules such asO2
, H2O2, OH radical andONOO

leading to further inflammation, subsequent infarction and
acute chest syndrome.22 Fat embolism from bone marrow in-
farction during a pain crisis or infection may produce an acute
chest syndrome. To decrease the rate of postoperative compli-
cations related to sickle cell disease, many improvements
have been made in the preoperative management. Currently,
this management includes pre-emptive erythrocyte transfu-
sion, aggressive hydratation, and avoidance of hypoxia, pain,
hypothermia and acidosis.8–10,18,19 These precautions decrease
morbidity andmortality rates according toHaberkern et al.1 De-
spite these precautions, acute chest syndrome occurs in 50% of
postoperative conditions. It is due to perioperative stress, hypo-
thermia, hypoxia, acidosis andpain,which cause erythrocyte to
sickle.23 In our serie, we did not observe any deaths from acute
chest syndrome, probably because of prompt treatment by
transfusion and oxygen, antibiotics, effective analgesia and
chestphysiology. It isprobably thebest treatmentof acute chest
syndrome as reported by other authors.16,245. Conclusion
Compared to the open approach, laparoscopy can lead to
more acute chest syndromewhich is themost lethal postoper-
ative complication after abdominal surgery. These findings
must be confirmed by further prospective randomized stud-
ies. As a result, in the meantime, when laparoscopy is per-
formed, great care must be taken, such as: operating with
low pressure (8–11 mmHg), extending the hospital stay be-
yond 3 days because acute chest syndrome is detected typi-
cally after day 2 or day 3.17 Patients must also have early
mobilization, effective pain control and intensive spirometry
in order to prevent lung complication.
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